SUBSCRIBE TO BJMO ONCOTALKS SERIES

All podcasts

 

Trastuzumab deruxtecan in the treatment of HER2-low metastatic breast cancer

Prof. Francois Duhoux and Prof. Mieke Van Bockstal (Cliniques universitaires St. Luc, Brussels)